Sun, Peter D.
- National Institute of Allergy and Infectious Diseases (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,327
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.1M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#3,327
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Sun, Peter D. as a PI. Multi-PI records show the full award amount for context.
- 1ZIAAI000697-30ZIAContact PIStructural and functional characterization of T and NK cell receptors$1.4Maward amount
- 1ZIAAI000880-23ZIAContact PIMechanism and pathways controlling HIV-1 viral release$468.1Kaward amount
- 1ZIAAI001263-04ZIAContact PIInhibition of COVID-19 associated acute fibrin deposition in lung$277.6Kaward amount
Award organization
Organizations that administered FY2023 awards listing Sun, Peter D. as a PI.
FY2023 award administered by National Institute of Allergy and Infectious Diseases ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardNational Institute of Allergy and Infectious Diseases
- 2007$500K Cumulative Funding
- 2007$1M Cumulative Funding
- 2007$2M Cumulative Funding
- 2007Entered Top 50% NationallyRanked #2130
- 2007Entered Top 25% NationallyRanked #2130
- 2009$5M Cumulative Funding
- 2011$10M Cumulative Funding
- 2011Entered Top 10% NationallyRanked #1557
- 2022$25M Cumulative Funding